PA
DCH

PharVision Advisers’s Dauch Corp DCH Stock Holding History

PharVision Advisers’s Portfolio DCH Stock Details DCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Sell
27,417
-48,377
-64% -$336K 1.65% 8
2025
Q4 		$486K Buy
75,794
+23,727
+46% +$148K 0.25% 46
2025
Q3 		$313K Buy
+52,067
New +$279K 0.18% 205
2025
Q1 		– Sell
-16,504
Closed -$96.2K – 290
2024
Q4 		$96.2K Buy
+16,504
New +$103K 0.08% 373

Other funds holding DCH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's DCH Position: Q1 2026 in Review

PharVision Advisers reduced its Dauch Corp (DCH) stake by 64% in Q1 2026, selling an estimated $336K and leaving 27,417 shares worth $163K. The position accounts for 1.65% of the portfolio, ranked #8.

PharVision Advisers first reported a position in DCH in Q4 2024 and has held it in 4 quarters since. The position peaked at $486K in Q4 2025. 296 funds tracked by Wall St. Rank hold DCH as of Q1 2026.

  • PharVision Advisers held 27,417 shares of Dauch Corp worth $163K as of Q1 2026.
  • PharVision Advisers sold 48,377 Dauch Corp shares in Q1 2026, an estimated $336K.
  • Dauch Corp made up 1.65% of PharVision Advisers's portfolio in Q1 2026, its #8 holding.
  • PharVision Advisers first reported a position in Dauch Corp in Q4 2024 and has held it in 4 quarters since.
  • PharVision Advisers's Dauch Corp position peaked at $486K in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Dauch Corp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.